The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC).
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Johanna C. Bendell
No Relationships to Disclose
 
James M. Cleary
Research Funding - Merck
Travel, Accommodations, Expenses - Roche
 
Paul Foster
No Relationships to Disclose
 
Wei Zhang
Employment - Genentech
 
Xian He
Employment - Genentech
 
Genevive Hernandez
Employment - Genentech
 
Koho Iizuka
Employment - Genentech
 
S. Gail Eckhardt
Consulting or Advisory Role - CASI Pharmaceuticals; Champions Biotechnology; Kyowa Hakko Kirin; Lilly/ImClone; OnKure; Pfizer; Sanofi; Suvica; Taiho Pharmaceutical
Research Funding - Aeglea Biotherapeutics (Inst); AstraZeneca (Inst); cleave biosciences (Inst); Genentech (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi; Taiho Pharmaceutical